about
Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancerAdenoviral vectors for prodrug activation-based gene therapy for cancerToxin-based therapeutic approachesNewly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsAdvancement and prospects of tumor gene therapySelective elimination of long INterspersed element-1 expressing tumour cells by targeted expression of the HSV-TK suicide gene.Stem cell based gene therapy in prostate cancerGlioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk geneProdrugs for improving tumor targetability and efficiency.Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.Live and let die: a new suicide gene therapy moves to the clinicGene therapy for malignant glioma.ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.A Positive Selection for Nucleoside Kinases in E. coliIn vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53.Encapsulated cell grafts to treat cellular deficiencies and dysfunction.Cell-based drug-delivery platforms.Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.Cells as delivery vehicles for cancer therapeutics.Cancer suicide gene therapy: a patent review.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy.Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression.A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin.Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy.Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth.In vivo characterization of horseradish peroxidase with indole-3-acetic acid and 5-bromoindole-3-acetic acid for gene therapy of cancer.The design and optimization of RNA trans-splicing molecules for skin cancer therapy.Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.
P2860
Q21261309-74FFF33D-D5C0-487F-8B62-C35E0C80F69BQ24642847-DAA3BD9D-DF34-474A-83E1-814A52658FEFQ26860729-79CB9113-9CCD-4A26-8406-1E9710B36A9BQ27013664-E92EFAE5-93DB-45B4-9D72-7386EE447F0EQ28477252-C651E924-E3DC-49AE-A69F-6D77C0A11D79Q33579330-08ACC693-C1E3-418A-96FE-0E4647172F60Q33888758-E544F521-92A2-490C-AC0B-C39850F1ECE9Q33997951-455F1DCB-EB62-4027-9E01-AABEF207D5C6Q34243638-AD6B1DDB-4A9A-44AA-A11A-9DDDA4AC190AQ34345491-2470BFB0-5CBF-499F-9082-FC710E0C5943Q35095165-10C154E6-AF40-43B6-96E9-48D34ADCBC81Q35176800-9D5B9475-92E4-484A-B721-C0691A76EB94Q35665170-E203270D-60AE-4E84-8EDA-30919E8B7F43Q35673628-96E0D82A-E879-4259-96FF-14B190AA0A10Q35686509-1638495C-4C8A-42EA-8360-6E8039A91134Q36146148-1A867976-E2C4-41ED-92FF-5834B6961BFBQ36176245-E6DB98AE-3454-4C6E-ABC8-7754FE3429ECQ36849213-7409FD31-7C1D-4E92-BDE6-27EF17BFBB2EQ37825339-420A0F2A-F75F-4D36-BDC1-8F1BE76A2E40Q37971089-BF365A1B-ACA1-40FA-9AF1-144EB5F96660Q38029631-D92E84A8-6699-4527-B31D-FA6FDEF52952Q38058289-C216DEBF-101D-44DE-96B5-FF96A60D2D40Q38226664-D5174E05-DB11-44C3-88A7-20579041148CQ38841046-5946903B-32DD-4ED9-ADA1-1F9AA8FC47E4Q38869957-460E9C56-8A83-47EA-A015-2EA4BFB1271DQ38893603-CD088167-85E8-432E-B262-E33A3BF5CA5FQ38895289-2074514A-46F6-4304-AA77-43A049D4605FQ39052958-24B70B7A-7A72-40DC-9F8D-24A020C07183Q39079666-E8150564-EE34-44D0-BEA6-6E18F8B1088AQ39114380-5D0E4894-8BC2-4CC6-8445-09292143EE22Q39140400-4CBEBFCE-F1A6-4DFA-8247-92D8C7B2A22CQ39195649-7177DB8B-F5B5-4164-8EC3-66F9A384B6D8Q39246483-40E96E36-F060-41FB-86F0-FF9A95B67F66Q39512141-993CBDBC-626B-4FA0-BB53-E8E39C4B6E65Q39577776-EDE124E4-9087-4E30-88F8-80AB2CA40B34Q39638959-37B6ED2C-EC31-4596-9082-598EA20DF600Q39751688-C6713644-8362-434E-BD11-820BE85D0A67Q41134396-40E9A7BE-59F8-453E-BC2B-D2A31176A4BCQ44763875-D214E2E7-E755-4AD8-90AD-CA2D9C0A240BQ45857108-C009C109-1E4C-4359-A568-F655F3FF469E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prodrug cancer gene therapy.
@en
Prodrug cancer gene therapy.
@nl
type
label
Prodrug cancer gene therapy.
@en
Prodrug cancer gene therapy.
@nl
prefLabel
Prodrug cancer gene therapy.
@en
Prodrug cancer gene therapy.
@nl
P1433
P1476
Prodrug cancer gene therapy
@en
P2093
Cestmir Altaner
P304
P356
10.1016/J.CANLET.2008.04.023
P407
P577
2008-05-27T00:00:00Z